Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is amyloid-β-peptide immunization clinically effective in patients with Alzheimer's disease?

Nature Clinical Practice Neurology volume 1, pages 84–85 (2005)Cite this article

boxed-textGilman S et al. (2005) Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial. Neurology 64: 1553–1562

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Wisniewski T and Frangione B (2005) Immunological and anti-chaperone therapeutic approaches for Alzheimer's disease. Brain Pathol 15: 72–77

    Article  CAS  Google Scholar 

  2. Nicoll JA et al. (2005) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 9: 448–452

    Article  Google Scholar 

  3. Ferrer I et al. (2004) Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. Brain Pathol 14: 11–20

    Article  CAS  Google Scholar 

  4. Masliah E et al. (2005) Aβ vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology 64: 129–131

    Article  CAS  Google Scholar 

  5. Fox NC et al. (2005) Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurol 64: 1563–1572

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Emma Campbell, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Neurology, Pathology and Psychiatry at New York University School of Medicine, New York, NY, USA

    Thomas Wisniewski

Authors
  1. Thomas Wisniewski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Wisniewski.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wisniewski, T. Is amyloid-β-peptide immunization clinically effective in patients with Alzheimer's disease?. Nat Rev Neurol 1, 84–85 (2005). https://doi.org/10.1038/ncpneuro0019

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0019

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing